Malaysia Healthcare Travel Council (MHTC) has signed MoUs with China’s International Medical Exchange & Cooperation Committee (IMECC) and Hangzhou Rende Maternity Hospital, in an effort to improve the patient experience for healthcare travellers from China to Malaysia.
Both partnerships will encourage knowledge exchange between MHTC and IMECC and Hangzhou Rende Maternity Hospital, respectively, through a series of virtually conducted Continuous Medical Education (CME) sessions, whereby Malaysian and Chinese healthcare experts will explore and discuss industry best practices and healthcare matters.
MHTC signs partnership with China’s International Medical Exchange & Cooperation Committee (IMECC) and Hangzhou Rende Maternity Hospital, as part of its long-term growth strategy
Additionally, the partnership with each respective entity will also open doors for patients from China to seek safe and trusted treatment options with MHTC members through virtual consultations.
MHTC CEO, Mohd Daud Mohd Arif, said in a press statement that the partnerships will ensure that healthcare travellers from China “benefit from a more holistic patient journey experience which offers continuity of care with excellent pre- and post-care services”.
Malaysia is an increasingly preferred healthcare destination for medical travellers from China, particularly since the country has been positioned regionally as the Fertility Hub of Asia and has experienced a 300 per cent increase in demand for fertility treatments between 2011 and 2016, according to an MHTC statement.
By the same token, Malaysia has also been positioned as the Cardiology Hub of Asia, being home to highly reputable cardio health institutions which have achieved many breakthroughs in the field of cardiology. Moving forward, Malaysia will also be showcased as the Cancer Centre of Excellence.
Malaysia Healthcare Travel Council (MHTC) has signed MoUs with China’s International Medical Exchange & Cooperation Committee (IMECC) and Hangzhou Rende Maternity Hospital, in an effort to improve the patient experience for healthcare travellers from China to Malaysia.
Both partnerships will encourage knowledge exchange between MHTC and IMECC and Hangzhou Rende Maternity Hospital, respectively, through a series of virtually conducted Continuous Medical Education (CME) sessions, whereby Malaysian and Chinese healthcare experts will explore and discuss industry best practices and healthcare matters.
Additionally, the partnership with each respective entity will also open doors for patients from China to seek safe and trusted treatment options with MHTC members through virtual consultations.
MHTC CEO, Mohd Daud Mohd Arif, said in a press statement that the partnerships will ensure that healthcare travellers from China “benefit from a more holistic patient journey experience which offers continuity of care with excellent pre- and post-care services”.
Malaysia is an increasingly preferred healthcare destination for medical travellers from China, particularly since the country has been positioned regionally as the Fertility Hub of Asia and has experienced a 300 per cent increase in demand for fertility treatments between 2011 and 2016, according to an MHTC statement.
By the same token, Malaysia has also been positioned as the Cardiology Hub of Asia, being home to highly reputable cardio health institutions which have achieved many breakthroughs in the field of cardiology. Moving forward, Malaysia will also be showcased as the Cancer Centre of Excellence.